ESR2 and breast cancer: In contrast to ERα, upregulation of ERβ has been shown to affect the survival of breast cancer cells in a similar manner as wild-type p53 including effects on cell cycle regulators, growth factor receptor and stress response signaling pathways [6, 47, 56].